Recurrent Type III Kounis Syndrome: Will Anti-Immunoglobulin E Drug Be Another Option?
Can J Cardiol
; 36(6): 966.e5-966.e6, 2020 06.
Article
de En
| MEDLINE
| ID: mdl-32536377
Kounis syndrome was recognized as the concurrence of acute cardiovascular events with hypersensitivity reactions. We report a case of Kounis syndrome type III (coronary thrombosis) variant in a 48-year-old man who had experienced recurrent acute myocardial infarctions after scallion-induced hypersensitivity reactions. After appropriate antithrombotic, antihistamine, and reperfusion strategies, the patient was found to have elevated levels of immunoglobulin E and chronic urticaria. Upon administration of omalizumab, there was an improvement of chronic urticaria, a decrease in immunoglobulin E levels, and resolution of the ischemic attacks.
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Thrombose coronarienne
/
Immunoglobuline E
/
Omalizumab
/
Hypersensibilité alimentaire
/
Syndrome de Kounis
/
Urticaire chronique
Type d'étude:
Diagnostic_studies
/
Etiology_studies
Limites:
Humans
/
Male
/
Middle aged
Langue:
En
Journal:
Can J Cardiol
Sujet du journal:
CARDIOLOGIA
Année:
2020
Type de document:
Article
Pays d'affiliation:
Chine
Pays de publication:
Royaume-Uni